| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.37 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |